How does the FoundationOne CGP improve the power of its test to detect an alteration that is present in only some, but not all, of the tumor cells?

How does the FoundationOne CGP improve the power of its test to detect an alteration that is present in only some, but not all, of the tumor cells?

How does the FoundationOne CGP improve the power of its test to detect an alteration that is present in only some, but not all, of the tumor cells?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professsor Hyun Cheol Chung, MD

Professsor Hyun Cheol Chung, MD

Professor of Medical Oncology
Director, Yonsei Song-Dang Institute for Cancer Research
Yonsei University College of Medicine
Seoul, Korea